What Is the Wegovy Pill and How Does It Work?

Written by the ClariDay clinical team. Medically reviewed by Ali Salih, GPhC-registered Pharmacist Independent Prescriber

Reviewed: 12 July 2026 · Next review: 12 August 2026 (one month, because licensing and availability for this new medicine are still moving)

Every claim in this article is linked to its source: the MHRA, the New England Journal of Medicine, or the product’s own trial data.

The Wegovy pill is a once-daily tablet form of semaglutide, the same medicine as the Wegovy injection, licensed by the MHRA on 11 June 2026 for weight management in the UK. It is the first GLP-1 weight-loss tablet licensed here, and it is only now reaching patients through private pharmacies. It works by quietening appetite and slowing how quickly your stomach empties, so you feel fuller and eat less.

For years the most effective weight-loss medicines came only as a weekly injection, and for anyone who dislikes needles that was often a barrier before they began. The Wegovy pill changes that. This guide covers what it is, how it works, how well it performs in trials, who can take it, and how to take it, in plain language and with UK sources you can check.

One thing to hold in mind as you read: this tablet is very new. The licence is a month old, and the first packs are only now reaching UK pharmacies, so nobody, including us, has long real-world experience with it yet. What does exist is years of experience with semaglutide itself, as the weekly injection and as a lower-dose tablet already used for type 2 diabetes. Where this guide speaks from experience, that is the experience it speaks from.

Is the Wegovy pill the same as the injection?

Yes, in the part that matters: it is the same active medicine, semaglutide. What differs is how it is delivered and how often you take it.

The Wegovy injection is semaglutide given once a week under the skin. The Wegovy pill is semaglutide given once a day as a tablet. The medicine doing the work inside your body is identical. The pill simply solves the delivery problem, getting a fragile molecule that would normally be destroyed in the stomach to survive long enough to be absorbed. More on that in a moment.

The doses do look confusing at first glance. The pill’s top dose is written as 25 mg and the injection’s as 2.4 mg, which reads as though the tablet were ten times stronger, but it is not stronger. Most of a swallowed dose never survives the journey through the gut, so the tablet starts with far more medicine in order to deliver a broadly similar amount into the blood. Think of the 25 mg tablet as the rough equivalent of the 2.4 mg injection, not a multiple of it [5].

The Wegovy pill is also not the same as Rybelsus, though Rybelsus is a semaglutide tablet too. Rybelsus is licensed for type 2 diabetes and goes up to a maximum of 14 mg a day. The new Wegovy tablet is licensed for weight management and goes up to 25 mg a day. Same molecule, different licence, different top dose. We cover that difference properly in our companion guide, Wegovy Tablets vs Rybelsus: Not the Same Medicine.

How does the Wegovy pill work?

Semaglutide is a GLP-1 receptor agonist. That is a long name for a simple idea: it copies a natural gut hormone, GLP-1, that your body releases after you eat.

That hormone does two useful things. It quietens the constant background hum of hunger, and it slows how quickly your stomach empties, so you feel full for longer [1]. For most people, the result is that eating less stops feeling like a fight. In a clinical study of oral semaglutide, people taking it ate less because their appetite and cravings genuinely eased, not through willpower [2]. That is the mechanism behind the weight change, and it is the same whether the semaglutide arrives by pill or by pen.

How does a tablet survive the stomach?

Semaglutide is a protein, and the stomach is very good at breaking proteins down. So the tablet travels with a chaperone, an absorption enhancer called SNAC.

Around the dissolving tablet, SNAC briefly raises the local pH and switches off the enzyme that would otherwise break the medicine down. That gives the semaglutide a short window to pass into the blood before the protection fades [3]. The effect is local and lasts only a little while, which is why how you take the tablet matters so much. We go deeper into this in How Do Wegovy Tablets Survive the Stomach? The SNAC Science.

This science also explains a rule your pharmacist will insist on: swallow the tablet whole, and never split, crush or chew it. The protection only works when the whole tablet dissolves where it was designed to, so half a tablet is not half a dose; it may be barely a dose at all [3][7]. If you find tablets hard to swallow, tell your prescriber, because there are better answers to that than a pill cutter.

How well does the Wegovy pill work?

In its main trial, the 25 mg Wegovy pill led to an average weight reduction of 13.6% over 64 weeks, compared with 2.2% for people taking a dummy tablet [4].

That trial was OASIS 4, published in the New England Journal of Medicine in September 2025, in 307 adults with overweight or obesity [4]. For someone starting at 100 kg (about 15 stone 10 lb), an average 13.6% is in the region of 13.6 kg, close to 2 stone 2 lb.

Two caveats sit alongside that figure, and they explain why you will see two different headline numbers for this tablet. The 13.6% is the real-world average across everyone in the group, including people who stopped early or never reached the full dose. Among those who took the tablet as intended throughout, the average was higher, 16.6% against 2.7% on placebo [4]. Neither number is wrong; they answer slightly different questions, and most press coverage leads with the 16.6%. To put the scale in everyday terms, close to 3 in 10 people across the whole trial group lost at least a fifth of their body weight [4]. And a second caveat holds for any trial: participants are carefully selected and closely supported, so everyday results are often more modest, with real people landing both above and below the average.

The other useful piece of context: this tablet performs in the same broad range as the 2.4 mg Wegovy injection [5]. So for many people the choice is less about which is stronger and more about which fits their life, a daily tablet or a weekly injection. We compare the two directly in Is Wegovy a Pill or an Injection? (It’s Now Both).

What might the first few weeks feel like?

Early experiences vary widely, and both ends of the range are normal. Some people notice their appetite quieten within days of the first tablet. Others feel little for weeks and start to wonder whether it is working at all. Neither pattern means anything is wrong. The full 25 mg dose, which produced the trial results above, is at least three months away, so a quiet start is expected.

If the tablet seems to be doing nothing, check the morning routine before you conclude it has failed. Absorption depends entirely on the empty-stomach rules described below, and the usual culprit is an early coffee, a breakfast that came too soon, or another tablet swallowed alongside it. Give the routine an honest fortnight. If nothing has changed after that, take it to your prescriber rather than increasing the dose yourself.

Who can take the Wegovy pill in the UK?

The Wegovy tablet is licensed for adults with a Body Mass Index (BMI) of 30 or above, or a BMI between 27 and 30 with at least one weight-related health condition, alongside a reduced-calorie diet and more physical activity [1].

It is a prescription-only medicine, so a prescriber has to assess whether it is right and safe for you before it can be supplied. There are two separate routes in the UK, and it helps to keep them apart.

On the NHS, access is decided by national rationing rules, and at launch this tablet is not available on the NHS. Whether and how the NHS will use it depends on an evaluation by the National Institute for Health and Care Excellence (NICE), which was still to come at the time of writing [1]. Privately, a prescriber assesses you against the medicine’s licensed use and their own clinical judgement, which is why a private route can be available while the NHS decision is still pending. Neither route is a shortcut around the assessment; both involve a qualified prescriber deciding it is appropriate for you.

A daily tablet can feel less medical than an injection, and some people with only a little to lose are already asking whether it might suit them. The thresholds above are the honest answer. This is a significant medicine with real side effects, studied in people living with obesity or with overweight plus a health condition, and it is not licensed for losing the last few pounds. If a prescriber says no on those grounds, that is the assessment doing its job.

How do you take the Wegovy pill?

The single most important thing to know is that this tablet only works if it is taken on an empty stomach.

Take it once a day when you first wake up, with no more than a sip of plain water, and then wait at least 30 minutes before eating, drinking anything else, or taking other medicines [6][7]. That waiting window is not fussiness. Because SNAC only protects the medicine locally and briefly, food or other drink in the stomach genuinely reduces how much is absorbed [6][7]. Getting this routine right is the difference between the tablet working and being wasted.

The dose is built up slowly on purpose. Treatment starts at 1.5 mg once daily and steps up through 4 mg, 9 mg and 25 mg, at least a month at each level [1][7]. The slow build keeps side effects manageable while your body settles in. If you are already on the 2.4 mg Wegovy injection, the licence allows a direct switch to the 25 mg tablet, which we come to below [1][7].

Fitting the empty-stomach rule into a real morning

On paper the rule is simple. In practice, three questions come up again and again.

The first is coffee. Until the 30 minutes are up, the only thing that should pass your lips is a little plain water. Tea, juice, flavoured water and coffee of any kind all count as breaking the rule, because anything beyond that small sip can reduce how much medicine is absorbed [6][7]. Your coffee is not being taken away from you; it is waiting half an hour.

The second is other medicines, and it catches people out because the 30-minute window applies to tablets as well as food. If you already take something that needs an empty stomach of its own, levothyroxine for an underactive thyroid being the everyday example, the two cannot simply be swallowed together, and your morning needs a plan. Sort this out with your prescriber before you start, and tell them everything you take in the morning, supplements included.

The third is mornings that do not run to a tidy clock: night shifts, small children, early starts. What matters is the principle, a genuinely empty stomach before, a sip of water with, and 30 clear minutes after, so if your day starts at an odd hour, agree a workable pattern with your prescriber rather than improvising one.

And if you miss a dose, skip it. Take the next tablet at the usual time the following morning, never two together, and never the missed one later in the day once you have eaten, because with food in the stomach it will not be absorbed properly [7]. Semaglutide stays in the body for a long time, so a single missed day does not undo your progress.

What are the side effects?

The most common side effects are digestive: nausea, diarrhoea, constipation and being sick [1]. In the main trial, gut-related side effects were the most frequent by some margin, affecting about three in four people on the tablet compared with about four in ten on placebo, but they were usually mild to moderate and tended to settle over time [4].

Two things tend to surprise people. Side effects often return briefly each time the dose steps up, so a settled stomach at the end of month one does not promise a quiet month two. Knowing that in advance stops a normal adjustment being mistaken for something going wrong. The other is belching, sometimes with an unpleasant sulphur taste, which people on oral semaglutide report often. The tablet can taste bitter too, and swallowing it promptly rather than letting it sit on the tongue helps. None of this is dangerous, and it usually eases, but it is kinder to know beforehand.

These are the same side effects seen with the injection, and most people find they ease as the body adjusts. Serious reactions are much less common, and a prescriber will talk you through the specific warnings and who should avoid the medicine before you start.

If a side effect is severe, persistent, or worrying you, speak to your prescriber rather than push through or change the dose yourself. Two things should not wait: vomiting where you cannot keep fluids down, and constipation that drags on for days despite drinking enough and moving about. Both are uncommon, and both can be sorted, but only if someone knows.

Can you switch from an injection to the Wegovy pill?

Yes, in many cases you can, and how straightforward it is depends entirely on which injection you are on.

If you are on the Wegovy injection, the switch is built into the licence: someone on the 2.4 mg weekly injection can move directly to the 25 mg daily tablet, without starting again from the lowest dose [1][7]. The medicine is the same; only the delivery changes. What changes for you is the rhythm, as one decision a week becomes one every morning, with the empty-stomach routine attached. Some people find a daily tablet easier to build into life, and others miss the simplicity of dealing with it once a week; both are reasonable ways to feel.

If you are on Mounjaro, the ground is different. Mounjaro’s active ingredient is tirzepatide, a different medicine that works on two gut-hormone signals rather than one, so there is no licensed direct switch to the semaglutide tablet, no neat dose conversion, and no promise that your body will respond the same way. People have understandable reasons for wanting to move, from tiredness of needles to travel, storage or side effects, and none of those reasons is wrong. It is simply a bigger decision than swapping one brand of the same thing for another, and a good prescriber will want to talk through why you are moving, where to start the dose, and what progress should look like a couple of months in.

Whichever direction you are moving, one thing stays true: do not run two GLP-1 medicines side by side, and do not arrange a switch yourself across two different providers. Tell one prescriber the whole picture and let them manage the change.

Can you get the Wegovy pill in the UK yet?

The tablet is licensed and, as of this month, is beginning to be supplied in the UK by private pharmacies. It is made by Novo Nordisk. It is not available on the NHS at launch, so in practice the current route is private prescribing [1].

If you have started comparing pharmacies, you may have noticed the same tablet at very different prices, sometimes behind steep introductory offers. There is no single official price for a private prescription. Each pharmacy sets its own, launch promotions are common in these first months, and a low headline figure is often a first-month rate rather than what the full dose will cost later.

The fair comparison is the total monthly cost at the dose you will actually stay on, with the clinical support included, not the introductory price of the starting dose. Overall, expect the tablet to sit in similar territory to the injections. Few people will find it a meaningfully cheaper way onto the same medicine.

Because it is so new, both availability and cost are moving quickly, and anywhere offering to sell a prescription-only medicine like this without a proper clinical assessment should be treated with real caution. The same goes for anything marketed as semaglutide “drops”, “sublingual” solutions or compounded alternatives, which are not the licensed tablet and have not been through this licensing process. The safe path is a qualified UK prescriber who assesses you first.

What can a prescriber honestly say this early?

Less than you might expect, and we would rather say so than pretend otherwise. The tablet is only days old in the UK, so no prescriber can yet point to their own patients who have done well on it. What we can offer is judgement built up over years of prescribing semaglutide in its other forms.

Here is where I stand on it this early, for what it is worth:

“From my perspective, oral Wegovy represents a welcome advance in obesity treatment, offering patients the potential benefits of GLP-1 therapy in a convenient tablet form. If it delivers comparable clinical outcomes to injectable treatment, it could broaden patient choice and improve uptake among those who are reluctant to use injections.”

— Ali Salih, Prescribing Pharmacist, ClariDay Clinic

That promise comes with a practical condition. The tablet is less forgiving than the pen. The injection works whatever kind of morning you are having; the tablet only rewards a steady routine. The people likely to do best are the ones honest with themselves about their mornings before they start. Chaotic mornings are not a reason to rule it out, but they are a reason to plan the routine with your prescriber first.

And if you try the tablet and find you prefer your pen, nothing has gone wrong. You have learned which of two good options suits you, and moving back is an ordinary conversation to have.

The bottom line

The Wegovy pill is a real milestone: the same effective medicine as the injection, now in a daily tablet, licensed in the UK since June 2026 and only now reaching patients. It works by easing appetite and slowing digestion, it performs in a similar range to the injection in trials, and its main catch is the empty-stomach routine, which has to be respected every single morning for the medicine to work. It is not right for everyone, and it is not available on the NHS yet, but for people who have been held back by needles, it is a genuinely new option worth discussing with a prescriber.

If you are considering treatment, you can book a consultation with a prescriber to talk through whether it fits you.

Frequently asked questions

Is the Wegovy pill the same as the Wegovy injection?

It contains the same active medicine, semaglutide. The difference is delivery and frequency: the pill is taken once daily as a tablet, the injection once weekly under the skin [1].

How much weight can you lose on the Wegovy pill?

In its main trial, people on the 25 mg tablet lost an average of 13.6% of their body weight over 64 weeks, versus 2.2% on placebo. Among those who took it as intended throughout, the average was 16.6% against 2.7% [4]. Everyday results are often more modest than trial averages.

How quickly does the Wegovy pill start working?

With any oral semaglutide, some people notice reduced appetite within days, while many feel little during the first weeks on the lower doses, which exist to let the body adjust. The full effect builds over months as the dose steps up to 25 mg. If nothing seems to be happening, check the empty-stomach routine before assuming the medicine is not working.

Can I have coffee before or straight after taking the Wegovy pill?

No. Until 30 minutes after the tablet, take only a small sip of plain water, because coffee, tea and other drinks reduce how much medicine is absorbed [6][7]. After the 30 minutes, you can drink whatever you like.

Can I split or halve the tablet?

No, never. The tablet’s absorption mechanism only works if it is swallowed whole; splitting or crushing it can mean almost none of the medicine is absorbed [3][7].

What should I do if I miss a dose?

Skip it and take the next dose at the usual time the following morning. Do not take two tablets, and do not take the missed one later in the day after eating. One missed day does not undo your progress [7].

Can I switch from Mounjaro to the Wegovy pill?

Not directly. Mounjaro contains tirzepatide, a different medicine, so there is no licensed straight swap or dose-conversion. Switching is possible but is a clinical decision for you and your prescriber, including what dose to start at.

Is the Wegovy pill available on the NHS?

Not at launch. The tablet is licensed in the UK but is not currently available on the NHS; NHS use depends on a NICE evaluation. A private prescriber can assess suitability separately [1].

Is the Wegovy pill the same as Rybelsus?

No. Both are semaglutide tablets, but Rybelsus is licensed for type 2 diabetes up to 14 mg, while the Wegovy tablet is licensed for weight management up to 25 mg [1].

Why do you have to take it on an empty stomach?

The tablet relies on a local absorption enhancer (SNAC) that only works briefly in the stomach. Food or drink reduces how much medicine is absorbed, so it is taken on waking with a sip of water, then a 30-minute wait before anything else [6][7].

Who can take the Wegovy pill?

Adults with a BMI of 30 or above, or 27 to 30 with a weight-related health condition, alongside diet and activity changes, once a prescriber has assessed that it is suitable [1].

References

[1] Medicines and Healthcare products Regulatory Agency. (2026, June 11). First GLP-1 tablet for weight loss approved in the UK. GOV.UK. https://www.gov.uk/government/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk

[2] Wharton, S., et al. (2024). Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15802

[3] Twarog, C., et al. (2022). Current understanding of sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) as an absorption enhancer: The oral semaglutide experience. Diabetes Spectrum. https://doi.org/10.2337/cd22-0118

[4] Aroda, V. R., et al. (2025). Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2500969

[5] Comparative analyses of oral semaglutide 25 mg versus subcutaneous semaglutide 2.4 mg for weight loss. (2025). Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70769

[6] Robertson, D. (2026, June 11). MHRA approves semaglutide oral tablets for weight loss. The Pharmaceutical Journal. https://pharmaceutical-journal.com/article/news/mhra-approves-semaglutide-oral-tablets-for-weight-loss

[7] Summary of Product Characteristics (SmPC): Wegovy 25 mg tablets (oral semaglutide). electronic medicines compendium (emc), product 102347. https://www.medicines.org.uk/emc/product/102347/smpc

This article is general information, not medical advice, and is not a substitute for a consultation with a qualified prescriber.